Barecetamab (ISU-104) is a humanized monoclonal antibody against tyrosine protein kinase ErbB3 with anticancer activity for use in investigational stage malignant solid tumors.
Purity:
96.40%
CAS Number:
[2275727-74-5]
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted